Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Zhi-Hua Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8675-5831; OpenAlex author ID A5100319825. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 5

  1. Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment. Last author DOI 10.1002/cam4.70550↗
  2. Risk Factors for Financial Toxicity in Patients With Pancreatic Cancer. Co-author DOI 10.1002/cam4.70799↗
  3. A phase 1b/2 study of first-line anti-PD-L1/ TGF-βRII fusion protein SHR-1701 combined with nab-paclitaxel and gemcitabine for advanced pancreatic ductal adeno… Co-author DOI 10.1038/s41392-025-02530-2↗
  4. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00125-014-3481-8↗
  5. Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell. Co-author DOI 10.1186/1479-5876-12-92↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Liu · 1 shared paper, 2025 · strength 0.30
  2. Baoxin Shi · 1 shared paper, 2025 · strength 0.30
  3. Jing Wang · 1 shared paper, 2025 · strength 0.30
  4. Xiuping Lai · 1 shared paper, 2025 · strength 0.25
  5. Jun Zhou · 1 shared paper, 2025 · strength 0.24
  6. Miaoyan Wei · 1 shared paper, 2025 · strength 0.24
  7. Lin Shen · 1 shared paper, 2025 · strength 0.24
  8. Ran Xue · 1 shared paper, 2025 · strength 0.24
  9. Xianjun Yu · 1 shared paper, 2025 · strength 0.24
  10. Yuhong Zhou · 1 shared paper, 2025 · strength 0.24
  11. Quanbo Zhou · 2 shared papers, 2014–2015 · strength 0.07
  12. Wenchao Gao · 2 shared papers, 2014–2015 · strength 0.07
  13. Huilin Ye · 2 shared papers, 2014–2015 · strength 0.07
  14. Langping Tan · 2 shared papers, 2014–2015 · strength 0.07
  15. Min Yu · 2 shared papers, 2014–2015 · strength 0.07
  16. Xiaohui Zhao · 1 shared paper, 2015 · strength 0.04
  17. Yimin Liu · 1 shared paper, 2015 · strength 0.04
  18. Yu Zhou · 1 shared paper, 2015 · strength 0.04
  19. Shangyou Zheng · 1 shared paper, 2015 · strength 0.04
  20. Rufu Chen · 1 shared paper, 2015 · strength 0.04
  21. Zhiqiang Fu · 1 shared paper, 2014 · strength 0.04
  22. Rufu Chen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.